Cargando…
High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
BACKGROUND: Patients with schizophrenia have an increased prevalence of metabolic disturbances compared with the general population. However, the mechanisms underlying the metabolic side effects of antipsychotics are unknown. The aim of the present study was to compare the levels of high-density lip...
Autores principales: | Ono, Shin, Sugai, Takuro, Suzuki, Yutaro, Yamazaki, Manabu, Shimoda, Kazutaka, Mori, Takao, Ozeki, Yuji, Matsuda, Hiroshi, Sugawara, Norio, Yasui-Furukori, Norio, Okamoto, Kurefu, Sagae, Toyoaki, Someya, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992846/ https://www.ncbi.nlm.nih.gov/pubmed/29879941 http://dx.doi.org/10.1186/s12888-018-1764-1 |
Ejemplares similares
-
Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2020) -
Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2016) -
High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey
por: Sugai, Takuro, et al.
Publicado: (2015) -
High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey
por: Sugai, Takuro, et al.
Publicado: (2016) -
Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)